The Current Ratio as of September 2024 (TTM) for Vaccitech plc (VACC) is 9.21

According to Vaccitech plc’s latest financial reports and current stock price. The company's current Current Ratio is 9.21. This represents a change of -37.13% compared to the average of 14.65 of the last 4 quarters.

Vaccitech plc (VACC) Historical Current Ratio (quarterly & annually)

How has VACC Current Ratio performed in the past?

The mean historical Current Ratio of Vaccitech plc over the last ten years is 11.70. The current 9.21 Current Ratio has changed 7.77% with respect to the historical average. Over the past ten years (40 quarters), VACC's Current Ratio was at its highest in in the September 2021 quarter at 38.60. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Vaccitech plc (VACC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vaccitech plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vaccitech plc (VACC) Average Current Ratio

How has VACC Current Ratio performed in the past?

The current Current Ratio of Vaccitech plc (VACC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vaccitech plc (VACC) Current Ratio vs. Peers

How is VACC’s Current Ratio compared to its peers?

Vaccitech plc’s Current Ratio is less than Molecular Partners AG (14.58), less than MediciNova, Inc. (18.24), greater than Anebulo Pharmaceuticals, Inc. (5.32), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), less than Edgewise Therapeutics, Inc. (30.24), less than Talaris Therapeutics, Inc. (18.64), less than Adicet Bio, Inc. (12.75), less than Cullinan Oncology, Inc. (28.87), greater than Vor Biopharma Inc. (6.54), less than Tyra Biosciences, Inc. (36.46), less than Third Harmonic Bio, Inc. (41.13), greater than C4 Therapeutics, Inc. (5.09), greater than Stoke Therapeutics, Inc. (6.67), less than Revolution Medicines, Inc. (15.42), less than Design Therapeutics, Inc. (41.42), greater than Achilles Therapeutics plc (8.24), less than Neoleukin Therapeutics, Inc. (15.33), less than Magenta Therapeutics, Inc. (14.64), less than Graphite Bio, Inc. (11.47), greater than CytomX Therapeutics, Inc. (1.00), less than Instil Bio, Inc. (15.06), greater than Spero Therapeutics, Inc. (2.68), greater than Assembly Biosciences, Inc. (2.74),

Build a custom stock screener for Vaccitech plc (VACC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccitech plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaccitech plc (VACC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaccitech plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.